application): Protein kinases play key roles in many cell signaling pathways, and enhanced activity of the protein kinases has been implicated in cancer and other proliferative diseases. Specific inhibitors would allow selective regulation of cell growth mechanisms and therefore, may be potentially useful cancer therapeutics. The overall goal of this project is to discover new classes of potent and specific inhibitors of individual serine/threonine and tyrosine protein kinases. The applicant proposes to approach this problem with a two-pronged combinatorial, transition state analog strategy to develop highly potent bisubstrate inhibitors.

Proposed Commercial Applications

NOT AVAILABLE

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA083955-01
Application #
2793639
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Program Officer
Lees, Robert
Project Start
1999-04-13
Project End
2000-03-31
Budget Start
1999-04-13
Budget End
2000-03-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Hawaii Biotech, Inc.
Department
Type
DUNS #
113226823
City
Aiea
State
HI
Country
United States
Zip Code
96701